Stocks and Investing Stocks and Investing
Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023

Graig Suvannavejh Initiated (AMLX) at Strong Buy and Held Target at $52 on, Mar 31st, 2023


Published on 2024-10-28 02:31:51 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Mizuho, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $52 on, Mar 31st, 2023.

Graig has made no other calls on AMLX in the last 4 months.



There are 4 other peers that have a rating on AMLX. Out of the 4 peers that are also analyzing AMLX, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $47 on, Tuesday, March 14th, 2023


These are the ratings of the 3 analyists that currently disagree with Graig


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Tuesday, March 14th, 2023
  • Itay Michaeli of "Citigroup" Maintained at Strong Buy with Increased Target to $54 on, Tuesday, March 14th, 2023
  • Geoff Meacham of "B of A Securities" Initiated at Strong Buy and Held Target at $50 on, Thursday, January 5th, 2023